Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities
ACS Chemical Biology · 2023
DOI: 10.1021/acschembio.3c00183 ↗Kurz gefasst
Fallbericht in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Eric M Kohn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: NCRR NIH HHS, Division of Graduate Education, Hartwell Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Theoretical Chemistry Institute, Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53705, United States.
ORCID-Profile: Xuhui Huang, Jeffrey D Martell
Förderung
- NCRR NIH HHS
- Division of Graduate Education
- Hartwell Foundation
- University of Wisconsin-Madison
Zitieren
APA
Kohn, E. M., Konovalov, K., Gomez, C. A., Hoover, G. N., Yik, A. K., Huang, X., & Martell, J. D. (2023). Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00183
Vancouver
Kohn EM, Konovalov K, Gomez CA, Hoover GN, Yik AK, Huang X, et al. Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities. ACS Chemical Biology. 2023. doi:10.1021/acschembio.3c00183
BibTeX
@article{Kohn2023,
author = {Kohn, Eric M and Konovalov, Kirill and Gomez, Christian A and Hoover, Gillian N and Yik, Andrew Kai-Hei and Huang, Xuhui and Martell, Jeffrey D},
title = {Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities},
journal = {ACS Chemical Biology},
year = {2023},
doi = {10.1021/acschembio.3c00183}
}
EUVIMED